|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Nurix Therapeutics, Inc. (NRIX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
15 |
|
|
Total
Direct Shares :
|
12,951,985 |
|
Total
Indirect Shares :
|
5,120,435 |
|
%
Held by Insiders:
|
27.53% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Wolff Stefani |
EVP and COO |
2023-05-01 |
6,113 |
2022-04-30 |
0 |
Beaurang Pierre |
Chief Business Officer |
2021-08-10 |
4,330 |
2021-08-10 |
116,666 |
Levin Mark J |
10% Owner |
2021-05-06 |
3,422,549 |
2021-05-06 |
260,392 |
Goeddel David V |
10% Owner |
2021-05-05 |
1,394,333 |
2021-05-05 |
1,420,954 |
Svennilson Peter |
10% Owner |
2021-05-05 |
1,394,333 |
2021-05-05 |
1,420,954 |
Van Houte Hans |
Chief Financial Officer |
2024-05-02 |
68,333 |
2021-02-18 |
0 |
Ring Christine |
Chief Legal Officer |
2024-06-03 |
19,838 |
2021-02-18 |
0 |
Hansen Gwenn |
Chief Scientific Officer |
2024-04-30 |
39,601 |
2020-11-30 |
0 |
Tjian Robert |
Director |
|
0 |
2020-07-28 |
124,999 |
Tepper Robert I |
10% Owner |
2020-07-28 |
5,422,549 |
2020-07-28 |
0 |
Green Jeremy |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
1,176,470 |
Wellington Biomedical Innovation Master Investors |
10% Owner |
2020-07-28 |
784,313 |
2020-07-28 |
0 |
Sands Arthur T |
Officer, Director |
2020-07-23 |
308,333 |
2020-07-23 |
600,000 |
Lacey David L. |
Director |
2020-07-23 |
33,333 |
|
0 |
Kunkel Lori Anne |
Director |
2020-07-23 |
54,027 |
|
0 |
|
|